Suppr超能文献

微小RNA-135a通过直接靶向人类胆囊癌中的极低密度脂蛋白受体发挥假定的肿瘤抑制作用。

MicroRNA-135a acts as a putative tumor suppressor by directly targeting very low density lipoprotein receptor in human gallbladder cancer.

作者信息

Zhou Huading, Guo Weijie, Zhao Yingjun, Wang Yifei, Zha Ruopeng, Ding Jie, Liang Linhui, Yang Guanghua, Chen Zongyou, Ma Baojin, Yin Baobing

机构信息

Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China.

出版信息

Cancer Sci. 2014 Aug;105(8):956-65. doi: 10.1111/cas.12463.

Abstract

The precise functions and mechanisms of microRNAs (miR) in gallbladder cancer (GBC) remain elusive. In this study, we found that miR-135a-5p expression is often dampened and correlated with neoplasm histologic grade in GBC. MicroRNA-135a-5p introduction clearly inhibited GBC cell proliferation in vitro and in vivo. Moreover, very low density lipoprotein receptor (VLDLR), which is often upregulated in GBC tissues, was identified as a direct functional target of miR-135a-5p. Furthermore, the p38 MAPK pathway was proven to be involved in miR-135a-VLDLR downstream signaling. Together, these results suggested that the miR-135a-VLDLR-p38 axis may contribute to GBC cell proliferation.

摘要

微小RNA(miR)在胆囊癌(GBC)中的精确功能和机制仍不清楚。在本研究中,我们发现miR-135a-5p的表达常常受到抑制,且与GBC的肿瘤组织学分级相关。引入MicroRNA-135a-5p明显抑制了GBC细胞在体外和体内的增殖。此外,在GBC组织中经常上调的极低密度脂蛋白受体(VLDLR)被确定为miR-135a-5p的直接功能靶点。此外,p38丝裂原活化蛋白激酶(MAPK)通路被证明参与了miR-135a-VLDLR的下游信号传导。总之,这些结果表明miR-135a-VLDLR-p38轴可能促进GBC细胞增殖。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7dac/4317855/edfb6ab173dc/cas0105-0956-f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验